Amrize (AMRZ) Cost of Revenue (2024 - 2026)

Amrize (AMRZ) has 3 years of Cost of Revenue data on file, last reported at $2.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 5.81% year-over-year to $2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $8.9 billion (up 3.37% YoY), and the FY2025 full-year result was $8.8 billion, up 1.7% from the prior year.
• Cost of Revenue declined to $2.0 billion in Q1 2026, from $2.1 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $2.6 billion in Q3 2025 to a low of $1.9 billion in Q1 2025.
• A 3-year average of $2.2 billion and a median of $2.2 billion in 2025 frame the typical range for Cost of Revenue.
• Peak annual rise in Cost of Revenue reached 7.7% in 2025, while the deepest fall reached 0.44% in 2025.
• Tracing AMRZ's Cost of Revenue over 3 years: stood at $2.1 billion in 2024, then grew by 0.34% to $2.1 billion in 2025, then decreased by 5.39% to $2.0 billion in 2026.
• Business Quant data shows AMRZ's Cost of Revenue at $2.0 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.6 billion in Q3 2025.